Theralase Technologies Inc. (OTCQX:TLTFF) Q1 2025 Earnings Conference Call June 9, 2025 11:00 AM ET Company Participants Kristina Hachey - CFO & Director Matthew Perraton - Corporate Participant Roger John Dumoulin-White - President, CEO & Director Matthew Perraton Good morning, everyone, and thank you for joining us today. I'm Matthew Perraton, Investor Relations Manager at Theralase Technologies, Inc., and it's a pleasure to welcome our shareholders and stakeholders to our first quarter 2025 Investor Conference Call.
Theralase Technologies Inc. (OTCQX:TLTFF) Q4 2024 Earnings Conference Call March 19, 2025 11:00 AM ET Company Participants Matthew Perraton - Chairman of the Board Kristina Hachey - Chief Financial Officer Roger Dumoulin-White - President and Chief Executive Officer Conference Call Participants Matthew Perraton Good morning, everyone. My name is Matthew Perraton and I will be hosting Theralase Technologies Inc's Quarterly Investor Conference Call today.
Theralase Technologies Inc. (OTCQX:TLTFF) Q3 2024 Earnings Conference Call December 4, 2024 11:00 AM ET Company Participants Matthew Perraton - Chairman of the Board Kristina Hachey - Chief Financial Officer Roger Dumoulin-White - President and Chief Executive Officer Conference Call Participants Matthew Perraton Good morning, everyone. My name is Matthew Perraton and I will be hosting Theralase Technologies Inc's Quarterly Investor Conference Call today.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Roger John Dumoulin-White CEO | NEO-L Exchange | CA88337V1004 ISIN |
| CA Country | 14 Employees | - Last Dividend | - Last Split | - IPO Date |
The fund is designed as an exchange-traded securities fund with a unique investment objective focused on providing daily exposure to the OBX Index, with a specific mechanism that amplifies the inverse movement of the index. This financial instrument is engineered to double the opposite performance of the OBX Index on a daily basis. This means that for each 1% decrease in the OBX Index, the fund aims to increase its value by approximately 2%, and conversely, for each 1% increase in the index, the fund's value is expected to decrease by approximately 2%. This leverage effect is central to the fund's strategy, although it's important to note that the fund and the Management Company do not guarantee a specific return. The OBX Index itself is a key barometer of the Oslo stock exchange’s market, comprising the 25 most liquid equities listed. It is a market-value weighted index, and its composition is revisited biannually to accurately reflect the market dynamics, guided by the Oslo Börs Index Methodology. This disciplined approach to index configuration ensures the OBX Index remains a relevant and representative benchmark of Norway's leading stock exchange.
Through its distinctive investment strategy, the fund offers a singular product designed to inverse-track the OBX Index with a leverage factor:
This fund provides investors with the opportunity to gain twice the inverse exposure to the daily performance of the OBX Index. It's a sophisticated financial instrument intended for investors looking to capitalize on or hedge against the downward movements of the Norwegian market's most liquid equities. The fund operates with a clear aim to double the opposite outcome of the OBX Index's daily performance, making it an aggressive investment option relative to traditional equity or index funds. Leveraged inverse ETFs like this are particularly suited for short-term trading strategies, given their daily reset mechanism, which can lead to compounding effects over multiple periods. It's crucial for potential investors to understand that the fund's performance is closely tied to daily market fluctuations, and the intended 2x inverse leverage outcome is calculated on a day-to-day basis.